Table 2 Macular retinal thickness in the overall cohort for PCA, tAD and control groups
Posterior cortical atrophy (n = 23) | Typical Alzheimer’s disease (n = 22) | Controls (n = 66) | PCA | tAD | |||
|---|---|---|---|---|---|---|---|
Beta | p value | Beta | p value | ||||
Total macular retinal thickness (mRT) | 266.9 (±16.3) | 267.8 (±13.6) | 269.3 (±13.6) | − 0.07 | 0.50 | − 0.09 | 0.38 |
Fovea | 223.0 (±19.1) | 227.7 (±21.5) | 224.3 (±23.8) | − 0.02 | 0.80 | 0.01 | 0.89 |
Superior inner | 286.8 (±20.3) | 289.6 (±15.9) | 290.0 (±18.9) | − 0.07 | 0.49 | − 0.06 | 0.56 |
Temporal inner | 276.0 (±17.0) | 278.2 (±12.1) | 276.0 (±17.4) | 0.00 | 1.00 | 0.01 | 0.92 |
Inferior inner | 287.8 (±18.3) | 288.0 (±11.5) | 289.6 (±17.2) | − 0.04 | 0.68 | − 0.09 | 0.35 |
Nasal inferior | 286.5 (±19.8) | 287.9 (±15.1) | 289.5 (±19.8) | − 0.06 | 0.53 | − 0.08 | 0.38 |
Superior outer | 263.4 (±18.2) | 269.3 (±20.4) | 268.4 (±15.5) | − 0.12 | 0.23 | − 0.01 | 0.89 |
Temporal outer | 246.2 (±15.9) | 246.8 (±13.9) | 247.7 (±14.8) | − 0.04 | 0.67 | − 0.06 | 0.57 |
Inferior outer | 259.0 (±19.8) | 258.6 (±14.5) | 261.3 (±15.2) | − 0.05 | 0.60 | − 0.09 | 0.35 |
Nasal outer | 281.3 (±17.8) | 280.5 (±16.7) | 285.0 (±16.1) | − 0.08 | 0.40 | − 0.14 | 0.15 |
Signal to noise ratio | 8.6 (±0.8) | 8.6 (±0.7) | 8.4 (±0.8) | 0.11 | 0.26 | 0.10 | 0.34 |